Sublingual 400 μg Misoprostol vs Intravenous 0.2 mg Methylergometrine for Active Management of Third Stage of Labor
Sindhu Bhute, Deepali Khamsara, Poonam Pandey
Citation Information :
Bhute S, Khamsara D, Pandey P. Sublingual 400 μg Misoprostol vs Intravenous 0.2 mg Methylergometrine for Active Management of Third Stage of Labor. J South Asian Feder Obs Gynae 2013; 5 (1):15-18.
Low dose sublingual misoprostol versus methylergometrine for active management of third stage of labour. J Obstet Gynecol Research 2008;34:820-23.
A randomized placebo controlled trial of oral misoprostol in the third stage of labour. Br J Obstet Gynecol 1998;105:971-75.
Misoprostol compared with methylergometrine for the prevention of postpartum haemorrhage: A double-blind randomized trial. Br J Obstet Gynecol 1999;106:1066-70.
400 ìg oral misoprostol versus 0.2 mg intravenous methylergometrine for the active management of third stage of labour. J Obstet Gynecol India 2009;59:228-34.
Misoprostol dose-related shivering and pyrexia in the third stage of labour. Br J Obstet Gynecol 1999;106:304-08.
Misoprostol in the management of the third stage of labour in the home delivery setting in rural Gambia: A randomized controlled trial. Br J Obstet Gynecol 2005;112: 1277-83.
Effects of sublingual misoprostol on severe postpartum haemorrhage in a primary health centre in Guinea-Bissau: Randomized double blind clinical trial. BMJ 2005;331:723-27.
WHO multicentric randomized trial of misoprostol in management of the third stage of labour. Lancet 2001;358:689-95.
